Loading…
← CockpitCompetitor Analysis › 002382.SZ Blue Sail Medical Co., Ltd. Class AOpen in the cockpit ↗

Blue Sail Medical Co., Ltd. Class A002382.SZCompetitor analysis, valuation and peers

China · CNY·Industrials›Miscellaneous Manufacturing
Momentum neutral 40
Mkt cap
$861M
US dollars, full cap
Free float
67%
of shares outstanding
$/day
$17.0M
20-day average traded
Fwd P/E
11.8×
forward earnings
ROIC−WACC
+0.8 pp
WACC 5.0%
Hurdle
-0 pp
Req g minus delivered
Next earnings
171 days
26 Apr 2027
Close · CNYCN¥5.64
1D-1.4%
1W+4.2%
1M-14.3%
3M-5.5%
6M-24.1%
YTD+0.7%
1Y-1.4%
ATR %4.0%
52w lowhigh36.7% off high

What Blue Sail Medical does

Employees: 8,962

Blue Sail Medical at a glance

Size Blue Sail Medical (002382.SZ) is a China Industrials company (Miscellaneous Manufacturing) with a market value of $861M, the 2598th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥5.64 on 6 Nov 2026.

Performance Over six months the shares fell 24.1%, against -13.0% for the median peer and -16.4% for the China market (cap-weighted) — 5th lowest of 21 in its peer set.

Growth Revenue grew 22.8% over the last twelve months (peer median +4.3%); the operating margin is 7.0% (peer median 10.0%).

Valuation It trades at 11.8× forward earnings against a peer median of 24.7× (2nd cheapest of 14).

Price implies For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is -6%, so the hurdle is -0 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.8 points above its cost of capital (5.0% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

70809010011 May 202611 Aug 20266 Nov 2026Peer median 84002382.SZ 77
Six months, rebased to 100: Blue Sail Medical against the median of its 20 peers (local-currency closes).

Blue Sail Medical financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥7.10BCN¥5.73BCN¥6.24BCN¥4.92BCN¥4.89B
Revenue growth—-8%+27%+1%—
Gross profitCN¥2.23BCN¥787MCN¥921MCN¥502MCN¥386M
EBITDAn/aCN¥254MCN¥326M-CN¥27.7M-CN¥141M
Net income-CN¥315M-CN¥759M-CN¥446M-CN¥568M-CN¥372M
Free cash flowCN¥526M-CN¥73.1M-CN¥632M-CN¥816M-CN¥364M
Capital expenditureCN¥399MCN¥553MCN¥774MCN¥774MCN¥897M
Total debtCN¥2.71BCN¥5.45BCN¥5.18BCN¥4.04BCN¥3.21B

Quarterly statements and history in the cockpit →

Blue Sail Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%0%300868GEN300196AP4603311300234688151600525300232FINPIPERHIM4583605128301000300434INH301003603657002382.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Blue Sail Medical is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%20×40×60×GEN300196AP4603311300232RHIM4583605128301000INH301003603657002382.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Blue Sail Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%GEN300196AP4688151600525300232FINPIPERHIM4583605128INH301003002382.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Blue Sail Medical is the large dot.

Blue Sail Medical competitors and peer comparison

How Blue Sail Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Blue Sail Medical against its 20 peers (data as of 6 Nov 2026)
Measure002382.SZPeer medianRank in peer set
1-month return-14.3%-8.3%6th lowest of 21
6-month return-24.1%-13.0%5th lowest of 21
Distance from 52-week high-36.7%-34.3%9th lowest of 21
Revenue growth (TTM)+22.8%+4.3%highest of 21
Operating margin7.0%10.0%10th lowest of 21
Forward P/E11.8×24.7×2nd cheapest of 14
Growth the price implies (Req g, 7 yrs)-6.5%9.8%3rd least demanding of 15
Growth delivered (Del g)-6.1%+4.3%2nd lowest of 15
Hurdle (Req g minus delivered)-0.4 pp+3.6 pp6th least demanding of 15
ROIC minus cost of capital+0.8 pp-0.6 pp9th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Blue Sail Medical 002382.SZChina$861M-24%+23%7%11.8×-6.5%-6.1%
Shenzhen Jame Technology 300868.SZChina$878M-36%+8%-7%n/an/an/a
Genuit GEN.LUnited Kingdom$897M+8%+4%12%12.1×12.4%+8.6%
Jiangsu Changhai Composite Materials 300196.SZChina$897M-25%+3%11%17.9×3.8%+9.0%
Riverstone AP4.SISingapore$824M-13%-4%25%15.5×2.1%-12.8%
Zhejiang Goldensea Hi-Tech 603311.SSChina$823M+28%+3%7%59.6×n/an/a
Zhejiang Kaier New Materials 300234.SZChina$816M+73%-17%-9%n/an/an/a
Hubei Huaqiang High-Tech 688151.SSChina$800M-22%+13%-5%n/a47.9%-5.6%
Changyuan Technology 600525.SSChina$799M-24%+7%-7%n/a-12.4%+5.1%
Unilumin 300232.SZChina$796M-23%+1%0%32.5×6.4%+10.3%
Finolex Industries FINPIPE.NSIndia$932M-20%+3%14%16.4×13.0%+3.5%
RHI Magnesita India RHIM.NSIndia$789M-13%+8%7%25.4×27.1%+24.1%
Apex Dynamics 4583.TWTaiwan$775M-58%+14%33%24.3×4.5%+1.1%
Shanghai Yanpu Precision Technology (Group) 605128.SSChina$978M-9%+3%9%27.1×15.4%+25.0%
Fuling Technology 001356.SZChina$756M-22%+17%6%n/an/an/a
Shanghai Hajime Advanced Material Technology 301000.SZChina$986M-1%+4%16%40.9×n/an/a
Sichuan Goldstone Asia Pharmaceutical 300434.SZChina$745M+8%-1%18%n/a12.2%+6.2%
Daoming Optics & Chemical 002632.SZChina$740M-28%-10%12%n/a7.5%+3.3%
INDUS INH.DEGermany$1.03B+11%+8%13%7.0×-6.8%+2.2%
Jiangsu Boiln Plastics 301003.SZChina$688M-11%+7%20%24.7×21.2%+3.6%
Jinhua Chunguang Technology 603657.SSChina$687M+16%+9%-3%45.2×n/an/a

Questions

Which companies are Blue Sail Medical's closest peers?
The cockpit's peer set: Shenzhen Jame Technology (300868.SZ), Genuit (GEN.L), Jiangsu Changhai Composite Materials (300196.SZ), Riverstone (AP4.SI), Zhejiang Goldensea Hi-Tech (603311.SS), Zhejiang Kaier New Materials (300234.SZ), Hubei Huaqiang High-Tech (688151.SS), Changyuan Technology (600525.SS).
Is Blue Sail Medical expensive compared with its peers?
On forward p/e it trades at 11.8× against a peer median of 24.7×, 2nd cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is -6%, so the hurdle is -0 pp: the price already allows for a slowdown.
How has Blue Sail Medical stock performed?
Over six months to 6 Nov 2026 the shares returned -24.1% against -13.0% for the median peer; over one year -1.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.